Oct 07, 2021 / 09:00PM GMT
Operator
Hello. Thank you for standing by for this conference call. (Operator Instructions) Thank you. Please be aware that today's conference call is being recorded.
I would now like to turn the call over to Christine Cassiano, Chief Communications Officer. Ms. Cassiano, please go ahead.
Christine Cassiano - Allogene Therapeutics, Inc. - Chief Communications Officer
Thank you, operator, and thanks to all of you for joining today on short notice. After the market closed today, Allogene issued a press release that provides a clinical update on our AlloCAR T program. The press release and today's webcast are both available on our website.
Today's call will be led by Dr. David Chang, our President and Chief Executive Officer. During the Q&A, he'll be joined by Dr. Rafael Amado, Executive Vice President of Research and Development and Chief Medical Officer; and Dr. Eric Schmidt, Chief Financial Officer.
We will do our best to get to as many questions as possible. As such, we ask you to limit questions to one per person so we can get to as
Allogene Therapeutics Inc Business Update- Conference Call Transcript
Oct 08, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers